Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 02 March 2018 |
| Author/s |
author: Alison M Gulbis Benigno C Valdez Roy B. Jones Chitra Hosing Richard E Champlin Michelle A Fanale Sarah A Milgrom Yasuhiro Oki Uday R Popat Chelsea Pinnix Amin M Alousi Elizabeth J Shpall Bouthaina S Dabaja Muzaffar Qazilbash Peter F Thall Yago Nieto Sairah Ahmed Partow Kebriaei |
| Publication date | March 2, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |